You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,835,460

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,835,460 protect, and when does it expire?

Patent 8,835,460 protects SUBSYS and is included in one NDA.

This patent has twenty-three patent family members in sixteen countries.

Summary for Patent: 8,835,460

Patent landscape, scope, and claims:

Title:	Sublingual fentanyl spray and methods of treating pain
Abstract:	The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s):	Kottayil; S. George (Long Grove, IL), Goskonda; Venkat R. (Phoenix, AZ), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Mount Prospect, IL), Parikh; Neha (Chicago, IL)
Assignee:	Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:	13/895,124
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,835,460
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Device; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,835,460

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-001	Jan 4, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-002	Jan 4, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-003	Jan 4, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-004	Jan 4, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-005	Jan 4, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-006	Aug 30, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-007	Aug 30, 2012		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y			TREATMENT OF PAIN	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,835,460

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2007208229	⤷ Subscribe
Brazil	PI0707235	⤷ Subscribe
Canada	2637672	⤷ Subscribe
China	101378735	⤷ Subscribe
Cyprus	1117263	⤷ Subscribe
Denmark	1976521	⤷ Subscribe
European Patent Office	1976521	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.